Not applicableEnded earlyNCT02394210What this trial is testingPost-authorisation Study of Biological Relapse in Patients With Multiple MyelomaWho this might be right forMultiple Myeloma Celgene 415
Not applicableActive Not RecruitingNCT06637202What this trial is testingSwebcg 91:A RT. Breast Conserving Surgery With or Without Radiotherapy for Breast Cancer PatientsWho this might be right forBreast Cancer Early Stage Breast Cancer (Stage 1-3) Region Skane 1,187
Not applicableStudy completedNCT01346696What this trial is testingStudy on OsseoSpeed™ TX Short Implants in a Chinese PopulationWho this might be right forPartially Edentulous Jaw Dentsply Sirona Implants and Consumables 45
Not applicableStudy completedNCT01473355What this trial is testingStudy on OsseoSpeed™ TX Narrow Implants in the Lower Jaw in a Chinese PopulationWho this might be right forPartially Edentulous Jaw Dentsply Sirona Implants and Consumables 45
Not applicableStudy completedNCT01389258What this trial is testingStudy on OsseoSpeed™ TX Narrow Implants in the Upper Jaw in a Chinese PopulationWho this might be right forPartially Edentulous Jaw Dentsply Sirona Implants and Consumables 45
Not applicableStudy completedNCT06360497What this trial is testingThe Effect of Mindfulness Meditation and Loving-kindness and Compassion Meditation on Psychological DistressWho this might be right forMM GroupLKCM GroupWaitlist Group Beijing Normal University 152
Not applicableStudy completedNCT06838065What this trial is testingRehabilitation Management for Patients with Multiple MyelomaWho this might be right forMultiple Myeloma Bone LesionsMultiple Myeloma (MM) Azienda USL Reggio Emilia - IRCCS 128
Not applicableStudy completedNCT01276886What this trial is testingItalian Study Group on Complicated DiverticulosisWho this might be right forDiverticulitis Gruppo Italiano per lo Studio della Diverticolite Complicata
Large-scale testing (Phase 3)Study completedNCT00838357What this trial is testingA Multi-centre, Open Label, Single-arm Study Intended to Further Investigate the Safety and Efficacy of Plerixafor as a Front-line Mobilisation Agent in Combination With G-CSF in Patients With Lymphoma or MM (Multiple Myeloma).Who this might be right forLymphoma (Non-Hodgkin's Lymphoma)Hodgkin's Disease or Multiple MyelomaFront Line Mobilization+1 more Genzyme, a Sanofi Company 118
Post-approval studies (Phase 4)Active Not RecruitingNCT03829371What this trial is testingSTUDY COMPARING TWO STANDARD TREATMENTS IN AUTOLOGOUS STEM CELL TRANSPLANTATION INELIGIBLE POPULATION AFFECTED BY MULTIPLE MYELOMAWho this might be right forMultiple Myeloma University of Turin, Italy 450